ED officials reach Tihar jail, arrests former Fortis promoter Shivinder Singh

Published On 2019-12-13 09:15 GMT   |   Update On 2022-12-10 08:55 GMT

Officials said an Enforcement Directorate (ED) team reached the Tihar jail here in the evening and placed former Fortis promoter Shivinder Singh under arrest as per provisions of the Prevention of Money Laundering Act (PMLA).


New Delhi: The ED on Thursday arrested former Fortis Healthcare promoter Shivinder Singh in a money laundering case related to alleged misappropriation of funds at Religare Finvest Ltd (RFL), officials said.


They said an Enforcement Directorate (ED) team reached the Tihar jail here in the evening and placed Shivinder Singh under arrest as per provisions of the Prevention of Money Laundering Act (PMLA).


Shivinder Singh was in judicial custody after the Delhi Police's Economic Offences Wing (EOW) had arrested him and others recently.


Also Read: Need further Custodial interrogation of former Fortis Healthcare promoter Malvinder Singh: ED tells Court


On Thursday, a Delhi Court had rejected his bail plea in the police case. He will be produced before a special PMLA court here on Friday with a plea to obtain his custody, the officials said.


Shivinder Singh's brother Malvinder (46), also a former Fortis Healthcare promoter, former CMD of Religare Enterprises Ltd (REL) Sunil Godhwani (58), Kavi Arora (48) and Anil Saxena were arrested by the EOW for allegedly diverting RFL's money and investing in other companies.


Malvinder and Godhwani were arrested earlier by the ED in this money laundering case.


The ED had told the court that both the brothers along with others had transferred an amount of about Rs 1,000 crore to various persons from entities linked to the corporate loan book and finally, the money was siphoned off and laundered.


RFL is a group firm of REL that was earlier promoted by the Singh brothers (Malivinder Mohan Singh and Shivinder Mohan Singh).


Read Also: Singh brothers, 3 others arrested for massive Rs 2400 crore fund misappropriation in Religare
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News